Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. (2013)

First Author: Feig C
Attributed to:  Confidence in Concept 2012 - Cambridge funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1073/pnas.1320318110

PubMed Identifier: 24277834

Publication URI: http://europepmc.org/abstract/MED/24277834

Type: Journal Article/Review

Volume: 110

Parent Publication: Proceedings of the National Academy of Sciences of the United States of America

Issue: 50

ISSN: 0027-8424